Home › Targets › TDP-43

TDP-43 (3 companies · 5 programs)

Companies with an active program directed at TDP-43.

ProMIS Neurosciences Inc. PMN

PMN267 — Amyotrophic Lateral Sclerosis Preclinical
PMN267 — Frontotemporal Dementia Preclinical

Voyager Therapeutics, Inc. VYGR

TDP-43 targeting small molecule — Amyotrophic Lateral Sclerosis Preclinical
TDP-43 targeting small molecule — Frontotemporal Dementia Preclinical

AC Immune SA ACIU

ACI-19626 — Frontotemporal Dementia Phase 1